Literature DB >> 9279144

Nitric oxide activity in childhood hypertension.

C D Goonasekera1, V Shah, D D Rees, M J Dillon.   

Abstract

OBJECTIVES: To investigate nitric oxide (NO) activity in childhood hypertension using nitrite and nitrate (NOx) concentrations in plasma as an index of nitric oxide generation.
DESIGN: Cross sectional study.
SETTING: Tertiary care paediatric centre and district general hospitals in the UK. PATIENTS: Children attending the above centre for treatment of hypertension. The control subjects were normotensive healthy children attending district general hospitals for minor medical and surgical disorders.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Plasma (P) and urinary (U) NOx concentrations, blood pressure, and glomerular filtration rate.
RESULTS: Sixteen normal children (mean age 6.9 years), 13 children with renovascular hypertension (mean age 7.8 years), and 25 children with hypertension associated with renal parenchymal disease (mean age 10.7 years) were studied. Mean (SD) PNOx values of children with hypertension with renovascular disease (15.3 (11.4) mumol/l) and renal parenchymal disease (18.3 (11.4) mumol/l) were significantly above that of normal children (11.9 (5.9) mumol/l) after accounting for age and glomerular filtration rate influences. Higher concentrations of PNOx in normal children were associated with younger age, but not in the children with hypertension. Higher PNOx concentrations were also associated with a lower glomerular filtration rate in normal children and children with hypertension with renal parenchymal disease, but not in the children with hypertension with renovascular disease. UNOx excretion expressed as a ratio against urine creatinine (Ucreat) excretion was not statistically different among the study groups.
CONCLUSIONS: PNOx is increased in children with hypertension even after statistical elimination of the glomerular filtration rate and age influences. This suggests a normal or increased NO synthase activity in childhood hypertension in contrast with adults with hypertension in whom it is described as reduced.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279144      PMCID: PMC1717257          DOI: 10.1136/adc.77.1.11

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  44 in total

1.  Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation.

Authors:  M Molnár; T Sütö; T Tóth; F Hertelendy
Journal:  Am J Obstet Gynecol       Date:  1994-05       Impact factor: 8.661

2.  Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia.

Authors:  S A Fickling; D Williams; P Vallance; S S Nussey; G S Whitley
Journal:  Lancet       Date:  1993-07-24       Impact factor: 79.321

3.  Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia.

Authors:  C Yallampalli; R E Garfield
Journal:  Am J Obstet Gynecol       Date:  1993-11       Impact factor: 8.661

4.  Metabolism and excretion of nitric oxide in humans. An experimental and clinical study.

Authors:  A Wennmalm; G Benthin; A Edlund; L Jungersten; N Kieler-Jensen; S Lundin; U N Westfelt; A S Petersson; F Waagstein
Journal:  Circ Res       Date:  1993-12       Impact factor: 17.367

5.  G-proteins in essential hypertension: a study of human platelet plasma membranes.

Authors:  A R McLellan; G Milligan; M D Houslay; J M Connell
Journal:  J Hypertens       Date:  1993-05       Impact factor: 4.844

6.  Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition.

Authors:  F J Salazar; A Alberola; J M Pinilla; J C Romero; T Quesada
Journal:  Hypertension       Date:  1993-07       Impact factor: 10.190

7.  Role of EDRF (nitric oxide) in diabetic renal hyperfiltration.

Authors:  N Bank; H S Aynedjian
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

8.  Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?

Authors:  F Habib; D Dutka; D Crossman; C M Oakley; J G Cleland
Journal:  Lancet       Date:  1994-08-06       Impact factor: 79.321

9.  Differential excretion of urinary proteins in children with vesicoureteric reflux and reflux nephropathy.

Authors:  P A Tomlinson; J M Smellie; N Prescod; R N Dalton; C Chantler
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

10.  Inhibition of nitric oxide synthesis increases blood pressure in healthy humans.

Authors:  W G Haynes; J P Noon; B R Walker; D J Webb
Journal:  J Hypertens       Date:  1993-12       Impact factor: 4.844

View more
  2 in total

1.  Plasma and urine nitric oxide levels in healthy Turkish children.

Authors:  Murat Elli; Oguz Söylemezoglu; Deniz Erbas; Sevcan A Bakkaloglu; Necla Buyan; Ozan Ozkaya; Enver Hasanoglu
Journal:  Pediatr Nephrol       Date:  2005-07-08       Impact factor: 3.714

2.  Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention.

Authors:  Fengyang Huang; Blanca Estela del-Río-Navarro; José Alfredo Pérez Ontiveros; Eliseo Ruiz-Bedolla; Efraín Navarro-Olivos; Santiago Villafaña; Guadalupe Bravo; Enrique Hong
Journal:  Endocrine       Date:  2012-09-29       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.